The company said that the new system is designed to enable physicians to complete complex interventional procedures, by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.

This is achieved using computer-controlled, externally-applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure. The core components of the system have received regulatory clearance in the US, Europe and Canada.

Dr Wei-Hsian Yin, chief of Cardiology at Cheng-Hsin General Hospital, said: “All too often during interventional procedures, we are required to spend quite a lot of time negotiating tortuous vessels. With the Stereotaxis system, we can get to where we need to go directly, enabling us to deliver therapy easily, in less time and with very low risk of an adverse event. The system also allows us to reduce x-ray exposure and contrast, which is of great benefit to the patient, as well as the physician.”

Mike Kaminski, president and chief executive officer of Stereotaxis, said: “Asia Pacific represents a strong growth opportunity for the Company, and we are very pleased with our momentum in that region. To date, we have sold 12 systems to hospitals in the region and are increasing our sales focus on Asia Pacific during 2010.”